Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D De Lucia

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|April 20, 2001
[Hypersensitivity to oral anticoagulants: report of a case]M M Patella, P E Russo, D De Lucia, et al.
Minerva Cardioangiologica|February 18, 1999
[Genetic polymorphisms as thrombotic risk factors in patients with arterial and venous ischemic episodes]D De Lucia, G Maisto, R Marotta, et al.
Chest|November 18, 2000
Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolismM Margaglione, V Brancaccio, D De Lucia, et al.
The Journal of Rheumatology|June 19, 1998
Association of primary antiphospholipid syndrome with inherited activated protein C resistanceU Picillo, D De Lucia, E Palatiello, et al.
Haematologica|February 22, 2000
Reversible adult respiratory distress in primary antiphospholipid syndromeA Camera, S Rocco, D De Lucia, et al.
Journal of Neuroimmunology|September 14, 2020
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetateE Signoriello, P Iardino, S Casertano, et al.
Thrombosis and Haemostasis|August 24, 1999
Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic controlF Zito, A Di Castelnuovo, A D'Orazio, et al.
European Journal of Clinical Pharmacology|September 29, 1999
Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1D Cozzolino, L Coppola, S Masi, et al.
Minerva Cardioangiologica|February 12, 2000
Molecular evidences for a hypercoagulable state in non insulin diabetes mellitus patients with a history of thrombotic episodesD De Lucia, S Pezzella, V Del Giudice, et al.
International Journal of Clinical & Laboratory Research|May 22, 1998
A hypercoagulable state in activated protein C resistant patients with ischemic strokeD De Lucia, D d'Alessio, S Pezzella, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|April 20, 2001
[Hypersensitivity to oral anticoagulants: report of a case]M M Patella, P E Russo, D De Lucia, et al.
Minerva Cardioangiologica|February 18, 1999
[Genetic polymorphisms as thrombotic risk factors in patients with arterial and venous ischemic episodes]D De Lucia, G Maisto, R Marotta, et al.
Chest|November 18, 2000
Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolismM Margaglione, V Brancaccio, D De Lucia, et al.
The Journal of Rheumatology|June 19, 1998
Association of primary antiphospholipid syndrome with inherited activated protein C resistanceU Picillo, D De Lucia, E Palatiello, et al.
Haematologica|February 22, 2000
Reversible adult respiratory distress in primary antiphospholipid syndromeA Camera, S Rocco, D De Lucia, et al.
Journal of Neuroimmunology|September 14, 2020
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetateE Signoriello, P Iardino, S Casertano, et al.
Thrombosis and Haemostasis|August 24, 1999
Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic controlF Zito, A Di Castelnuovo, A D'Orazio, et al.
European Journal of Clinical Pharmacology|September 29, 1999
Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1D Cozzolino, L Coppola, S Masi, et al.
Minerva Cardioangiologica|February 12, 2000
Molecular evidences for a hypercoagulable state in non insulin diabetes mellitus patients with a history of thrombotic episodesD De Lucia, S Pezzella, V Del Giudice, et al.
International Journal of Clinical & Laboratory Research|May 22, 1998
A hypercoagulable state in activated protein C resistant patients with ischemic strokeD De Lucia, D d'Alessio, S Pezzella, et al.
Pageof 4